
Gold, Silver Focus ...


| Price and Volume | |
|---|---|
| Recent Price | 24.84 |
| 52 Week High | 30.20 |
| 52 Week Low | 18.37 |
| Avg. Daily Vol. (Mil) | 0.19 |
| Beta (3 year) | 1.44 |
| Share Related Items | |
| Mkt Cap (Mil) | 402.75 |
| Shares Out (Mil) | 16.21 |
| Float (Mil) | 14.09 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.40 |
| Current Ratio | 5.50 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 31.40 |
| Price/Sales | 2.52 |
| Price/Book | 2.02 |
| Price/Cash Flow | 20.70 |
| Per Share Data | |
| Earnings | 0.79 |
| Sales | 9.87 |
| Book Value | 12.31 |
| Cash Flow | 1.20 |
| Business Summary | |
|---|---|
| Cynosure, Inc., develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures. | |
| General Information | |
| 5 Carlisle Road
Westford, MA 01886 |
|
| www.cynosurelaser.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 378 | |
| CEO: Michael R. Davin | |
| Short Interest | |
| Current Month (Mil) | 0.75 |
| Previous Month (Mil) | 0.67 |
| Short Interest Ratio (Days) | 4.30 |
| Management Effectiveness | |
| Return on Equity | 6.10 |
| Return on Assets | 5.10 |
| Return on Investments | 6.10 |
| Profitability | |
| Gross Margin | 62.00 |
| EBIT Margin | 8.30 |
| Profit Margin | 7.60 |